Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-25,332
Closed -$7.07M 70
2025
Q2
$7.07M Buy
+25,332
New +$7.18M 0.75% 50
2024
Q4
Sell
-12,257
Closed -$3.95M 75
2024
Q3
$3.95M Buy
12,257
+1,372
+13% +$449K 0.42% 59
2024
Q2
$3.4M Sell
10,885
-606
-5% -$178K 0.35% 65
2024
Q1
$3.27M Buy
+11,491
New +$3.36M 0.33% 72

Other funds holding AMGN

Longbow Finance's AMGN Position: Q3 2025 in Review

Longbow Finance sold out of Amgen (AMGN) in Q3 2025, closing a stake of 25,332 shares — an estimated $7.07M sold.

Longbow Finance first reported a position in AMGN in Q1 2024 and held it in 4 quarters. The position peaked at $7.07M in Q2 2025. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • Longbow Finance reported no remaining Amgen position as of Q3 2025 after selling out during the quarter.
  • Longbow Finance sold 25,332 Amgen shares in Q3 2025, an estimated $7.07M.
  • Longbow Finance first reported a position in Amgen in Q1 2024 and held it in 4 quarters.
  • Longbow Finance's Amgen position peaked at $7.07M in Q2 2025.
  • 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on Longbow Finance's 13F filing for Q3 2025, filed 6 Nov 2025.